Literature DB >> 32504093

Correction of amyotrophic lateral sclerosis related phenotypes in induced pluripotent stem cell-derived motor neurons carrying a hexanucleotide expansion mutation in C9orf72 by CRISPR/Cas9 genome editing using homology-directed repair.

Nidaa A Ababneh1,2, Jakub Scaber1, Rowan Flynn3, Andrew Douglas4,5, Paola Barbagallo1, Ana Candalija1, Martin R Turner1, David Sims6, Ruxandra Dafinca1, Sally A Cowley3, Kevin Talbot1.   

Abstract

The G4C2 hexanucleotide repeat expansion (HRE) in C9orf72 is the commonest cause of familial amyotrophic lateral sclerosis (ALS). A number of different methods have been used to generate isogenic control lines using clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 and non-homologous end-joining by deleting the repeat region, with the risk of creating indels and genomic instability. In this study, we demonstrate complete correction of an induced pluripotent stem cell (iPSC) line derived from a C9orf72-HRE positive ALS/frontotemporal dementia patient using CRISPR/Cas9 genome editing and homology-directed repair (HDR), resulting in replacement of the excised region with a donor template carrying the wild-type repeat size to maintain the genetic architecture of the locus. The isogenic correction of the C9orf72 HRE restored normal gene expression and methylation at the C9orf72 locus, reduced intron retention in the edited lines and abolished pathological phenotypes associated with the C9orf72 HRE expansion in iPSC-derived motor neurons (iPSMNs). RNA sequencing of the mutant line identified 2220 differentially expressed genes compared with its isogenic control. Enrichment analysis demonstrated an over-representation of ALS relevant pathways, including calcium ion dependent exocytosis, synaptic transport and the Kyoto Encyclopedia of Genes and Genomes ALS pathway, as well as new targets of potential relevance to ALS pathophysiology. Complete correction of the C9orf72 HRE in iPSMNs by CRISPR/Cas9-mediated HDR provides an ideal model to study the earliest effects of the hexanucleotide expansion on cellular homeostasis and the key pathways implicated in ALS pathophysiology.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32504093      PMCID: PMC7399532          DOI: 10.1093/hmg/ddaa106

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  46 in total

1.  Combinatorial analysis of developmental cues efficiently converts human pluripotent stem cells into multiple neuronal subtypes.

Authors:  Yves Maury; Julien Côme; Rebecca A Piskorowski; Nouzha Salah-Mohellibi; Vivien Chevaleyre; Marc Peschanski; Cécile Martinat; Stéphane Nedelec
Journal:  Nat Biotechnol       Date:  2014-11-10       Impact factor: 54.908

2.  Extensive size variability of the GGGGCC expansion in C9orf72 in both neuronal and non-neuronal tissues in 18 patients with ALS or FTD.

Authors:  Angelica Nordin; Chizuru Akimoto; Anna Wuolikainen; Helena Alstermark; Pär Jonsson; Anna Birve; Stefan L Marklund; Karin S Graffmo; Karin Forsberg; Thomas Brännström; Peter M Andersen
Journal:  Hum Mol Genet       Date:  2015-02-23       Impact factor: 6.150

3.  ANAQUIN: a software toolkit for the analysis of spike-in controls for next generation sequencing.

Authors:  Ted Wong; Ira W Deveson; Simon A Hardwick; Tim R Mercer
Journal:  Bioinformatics       Date:  2017-06-01       Impact factor: 6.937

4.  Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study.

Authors:  Elisa Majounie; Alan E Renton; Kin Mok; Elise G P Dopper; Adrian Waite; Sara Rollinson; Adriano Chiò; Gabriella Restagno; Nayia Nicolaou; Javier Simon-Sanchez; John C van Swieten; Yevgeniya Abramzon; Janel O Johnson; Michael Sendtner; Roger Pamphlett; Richard W Orrell; Simon Mead; Katie C Sidle; Henry Houlden; Jonathan D Rohrer; Karen E Morrison; Hardev Pall; Kevin Talbot; Olaf Ansorge; Dena G Hernandez; Sampath Arepalli; Mario Sabatelli; Gabriele Mora; Massimo Corbo; Fabio Giannini; Andrea Calvo; Elisabet Englund; Giuseppe Borghero; Gian Luca Floris; Anne M Remes; Hannu Laaksovirta; Leo McCluskey; John Q Trojanowski; Vivianna M Van Deerlin; Gerard D Schellenberg; Michael A Nalls; Vivian E Drory; Chin-Song Lu; Tu-Hsueh Yeh; Hiroyuki Ishiura; Yuji Takahashi; Shoji Tsuji; Isabelle Le Ber; Alexis Brice; Carsten Drepper; Nigel Williams; Janine Kirby; Pamela Shaw; John Hardy; Pentti J Tienari; Peter Heutink; Huw R Morris; Stuart Pickering-Brown; Bryan J Traynor
Journal:  Lancet Neurol       Date:  2012-03-09       Impact factor: 44.182

5.  Partial inhibition of the overactivated Ku80-dependent DNA repair pathway rescues neurodegeneration in C9ORF72-ALS/FTD.

Authors:  Rodrigo Lopez-Gonzalez; Dejun Yang; Mochtar Pribadi; Tanya S Kim; Gopinath Krishnan; So Yoen Choi; Soojin Lee; Giovanni Coppola; Fen-Biao Gao
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-24       Impact factor: 12.779

6.  C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci.

Authors:  Sarah Mizielinska; Tammaryn Lashley; Frances E Norona; Emma L Clayton; Charlotte E Ridler; Pietro Fratta; Adrian M Isaacs
Journal:  Acta Neuropathol       Date:  2013-10-30       Impact factor: 17.088

7.  Genetic Correction of SOD1 Mutant iPSCs Reveals ERK and JNK Activated AP1 as a Driver of Neurodegeneration in Amyotrophic Lateral Sclerosis.

Authors:  Akshay Bhinge; Seema C Namboori; Xiaoyu Zhang; Antonius M J VanDongen; Lawrence W Stanton
Journal:  Stem Cell Reports       Date:  2017-03-30       Impact factor: 7.765

8.  Reduced autophagy upon C9ORF72 loss synergizes with dipeptide repeat protein toxicity in G4C2 repeat expansion disorders.

Authors:  Manon Boivin; Véronique Pfister; Angeline Gaucherot; Frank Ruffenach; Luc Negroni; Chantal Sellier; Nicolas Charlet-Berguerand
Journal:  EMBO J       Date:  2020-01-13       Impact factor: 11.598

9.  C9orf72 nucleotide repeat structures initiate molecular cascades of disease.

Authors:  Aaron R Haeusler; Christopher J Donnelly; Goran Periz; Eric A J Simko; Patrick G Shaw; Min-Sik Kim; Nicholas J Maragakis; Juan C Troncoso; Akhilesh Pandey; Rita Sattler; Jeffrey D Rothstein; Jiou Wang
Journal:  Nature       Date:  2014-03-05       Impact factor: 49.962

10.  C9orf72 Hexanucleotide Expansions Are Associated with Altered Endoplasmic Reticulum Calcium Homeostasis and Stress Granule Formation in Induced Pluripotent Stem Cell-Derived Neurons from Patients with Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.

Authors:  Ruxandra Dafinca; Jakub Scaber; Nida'a Ababneh; Tatjana Lalic; Gregory Weir; Helen Christian; Jane Vowles; Andrew G L Douglas; Alexandra Fletcher-Jones; Cathy Browne; Mahito Nakanishi; Martin R Turner; Richard Wade-Martins; Sally A Cowley; Kevin Talbot
Journal:  Stem Cells       Date:  2016-05-04       Impact factor: 6.277

View more
  13 in total

Review 1.  Nuclear pore complexes - a doorway to neural injury in neurodegeneration.

Authors:  Alyssa N Coyne; Jeffrey D Rothstein
Journal:  Nat Rev Neurol       Date:  2022-04-29       Impact factor: 42.937

Review 2.  Human stem cell models of neurodegeneration: From basic science of amyotrophic lateral sclerosis to clinical translation.

Authors:  Elisa Giacomelli; Björn F Vahsen; Elizabeth L Calder; Yinyan Xu; Jakub Scaber; Elizabeth Gray; Ruxandra Dafinca; Kevin Talbot; Lorenz Studer
Journal:  Cell Stem Cell       Date:  2022-01-06       Impact factor: 24.633

3.  C9orf72 ALS/FTD dipeptide repeat protein levels are reduced by small molecules that inhibit PKA or enhance protein degradation.

Authors:  Nausicaa V Licata; Riccardo Cristofani; Sally Salomonsson; Katherine M Wilson; Liam Kempthorne; Deniz Vaizoglu; Vito G D'Agostino; Daniele Pollini; Rosa Loffredo; Michael Pancher; Valentina Adami; Paola Bellosta; Antonia Ratti; Gabriella Viero; Alessandro Quattrone; Adrian M Isaacs; Angelo Poletti; Alessandro Provenzani
Journal:  EMBO J       Date:  2021-11-18       Impact factor: 11.598

Review 4.  CRISPR-Cas9-Mediated Gene Therapy in Neurological Disorders.

Authors:  Lihong Guan; Yawei Han; Ciqing Yang; Suxiang Lu; Jiang Du; Han Li; Juntang Lin
Journal:  Mol Neurobiol       Date:  2021-11-23       Impact factor: 5.590

Review 5.  Therapeutic strategies for C9orf72 amyotrophic lateral sclerosis and frontotemporal dementia.

Authors:  Guillaume M Hautbergue; John D Cleary; Shu Guo; Laura P W Ranum
Journal:  Curr Opin Neurol       Date:  2021-10-01       Impact factor: 6.283

6.  CRISPR/Cas9-mediated excision of ALS/FTD-causing hexanucleotide repeat expansion in C9ORF72 rescues major disease mechanisms in vivo and in vitro.

Authors:  Katharina E Meijboom; Abbas Abdallah; Nicholas P Fordham; Hiroko Nagase; Tomás Rodriguez; Carolyn Kraus; Tania F Gendron; Gopinath Krishnan; Rustam Esanov; Nadja S Andrade; Matthew J Rybin; Melina Ramic; Zachary D Stephens; Alireza Edraki; Meghan T Blackwood; Aydan Kahriman; Nils Henninger; Jean-Pierre A Kocher; Michael Benatar; Michael H Brodsky; Leonard Petrucelli; Fen-Biao Gao; Erik J Sontheimer; Robert H Brown; Zane Zeier; Christian Mueller
Journal:  Nat Commun       Date:  2022-10-21       Impact factor: 17.694

Review 7.  Novel genome-editing-based approaches to treat motor neuron diseases: Promises and challenges.

Authors:  Annarita Miccio; Panagiotis Antoniou; Sorana Ciura; Edor Kabashi
Journal:  Mol Ther       Date:  2021-04-03       Impact factor: 11.454

8.  Axonal TDP-43 condensates drive neuromuscular junction disruption through inhibition of local synthesis of nuclear encoded mitochondrial proteins.

Authors:  Topaz Altman; Ariel Ionescu; Amjad Ibraheem; Dominik Priesmann; Tal Gradus-Pery; Luba Farberov; Gayster Alexandra; Natalia Shelestovich; Ruxandra Dafinca; Noam Shomron; Florence Rage; Kevin Talbot; Michael E Ward; Amir Dori; Marcus Krüger; Eran Perlson
Journal:  Nat Commun       Date:  2021-11-25       Impact factor: 14.919

9.  G4C2 Repeat RNA Initiates a POM121-Mediated Reduction in Specific Nucleoporins in C9orf72 ALS/FTD.

Authors:  Alyssa N Coyne; Benjamin L Zaepfel; Lindsey Hayes; Boris Fitchman; Yuval Salzberg; En-Ching Luo; Kelly Bowen; Hannah Trost; Stefan Aigner; Frank Rigo; Gene W Yeo; Amnon Harel; Clive N Svendsen; Dhruv Sareen; Jeffrey D Rothstein
Journal:  Neuron       Date:  2020-07-15       Impact factor: 17.173

10.  Translation of the poly(GR) frame in C9ORF72-ALS/FTD is regulated by cis-elements involved in alternative splicing.

Authors:  Alexa Lampasona; Sandra Almeida; Fen-Biao Gao
Journal:  Neurobiol Aging       Date:  2021-05-08       Impact factor: 5.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.